Literature DB >> 31149259

TRABECULAR BONE SCORE (TBS) HAS A POOR DISCRIMINATIVE POWER FOR VERTEBRAL FRACTURES IN 153 ROMANIAN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.

D Grigorie1,2, D Coles1, A Sucaliuc1,2.   

Abstract

CONTEXT: Trabecular Bone Score (TBS) has been recently proposed as a good tool to investigate secondary osteoporosis.
OBJECTIVE: The aim of this study was to assess TBS from spine DXA images in patients with primary hyperparathyroidism (PHPT) and look at its correlates. SUBJECTS AND METHODS: 153 patients, mean age 59.1 ± 12.1 yrs, females and males (10%), mean BMI 26.2 ± 4.8 kg/m2, mean serum calcium and PTH of 11.3 ± 1.2 mg/dL and 232 ± 329 pg/mL, respectively; 89% had osteoporosis/osteopenia by LS DXA and 46% had renal involvement. There were 7.6% patients with vertebral fractures, 13.2% patients with nonvertebral fractures. TBS indices were derived from LS-DXA images and cutoff points used were those previously reported.
RESULTS: Mean TBS was in the partially degraded range (1.258 ± 0.115); 32% of patients had degraded microarchitecture (TBS ≤ 1.20), 51% had partially degraded microarchitecture (TBS > 1.20 and < 1.35) and 17% had normal TBS. TBS was significantly correlated with areal BMD both at the LS (r=0.544; p<0.001) and FN (r = 0.315; p < 0.001), and negatively with age (r= - 0.354; p < 0.001) and years since menopause - YSM (r = - 0.257, p = 0.005). Patients with vertebral fractures had mean values of TBS in the degraded range, significantly lower than those without vertebral fractures (1.173 ± 0.076 vs. 1.263 ± 0.115; p = 0.006). The presence of vertebral fracture was independently associated only with YSM (OR = 1.131, 95% CI = 0.032 - 0.214, p = 0.008) but not with TBS.
CONCLUSIONS: In a cohort of symptomatic PHPT patients, including postmenopausal, premenopausal and male patients, we have shown that TBS was in the partially degraded range, but it was not independently associated with fractures.

Entities:  

Keywords:  BMI; Bone Mineral Density; Primary hyperparathyroidism; Trabecular Bone Score; fractures

Year:  2018        PMID: 31149259      PMCID: PMC6516507          DOI: 10.4183/aeb.2018.208

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  17 in total

1.  Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment.

Authors:  Paul D Miller; Ethel S Siris; Elizabeth Barrett-Connor; Kenneth G Faulkner; Lois E Wehren; Thomas A Abbott; Ya-Ting Chen; Marc L Berger; Arthur C Santora; Louis M Sherwood
Journal:  J Bone Miner Res       Date:  2002-12       Impact factor: 6.741

2.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.

Authors:  Didier Hans; Andrew L Goertzen; Marc-Antoine Krieg; William D Leslie
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

3.  Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae.

Authors:  Didier Hans; Nicole Barthe; Stephanie Boutroy; Laurent Pothuaud; Renaud Winzenrieth; Marc-Antoine Krieg
Journal:  J Clin Densitom       Date:  2011-07-02       Impact factor: 2.617

4.  The risk of fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Simona De Geronimo; Elisabetta Romagnoli; Daniele Diacinti; Emilio D'Erasmo; Salvatore Minisola
Journal:  Eur J Endocrinol       Date:  2006-09       Impact factor: 6.664

5.  Primary hyperparathyroidism and the risk of fracture: a population-based study.

Authors:  S Khosla; L J Melton; R A Wermers; C S Crowson; W m O'Fallon; B l Riggs
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

6.  Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

7.  Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Authors:  Emily M Stein; Barbara C Silva; Stephanie Boutroy; Bin Zhou; Ji Wang; Julia Udesky; Chiyuan Zhang; Donald J McMahon; Megan Romano; Elzbieta Dworakowski; Aline G Costa; Natalie Cusano; Dinaz Irani; Serge Cremers; Elizabeth Shane; X Edward Guo; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

8.  Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study.

Authors:  S Boutroy; D Hans; E Sornay-Rendu; N Vilayphiou; R Winzenrieth; R Chapurlat
Journal:  Osteoporos Int       Date:  2012-10-16       Impact factor: 4.507

9.  Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Edda Vignali; Giuseppe Viccica; Daniele Diacinti; Filomena Cetani; Luisella Cianferotti; Elena Ambrogini; Chiara Banti; Romano Del Fiacco; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

10.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

View more
  2 in total

1.  BONE QUALITY IN A YOUNG COHORT OF HIV-POSITIVE PATIENTS.

Authors:  A R Negru; C Tiliscan; A M Tudor; D I Munteanu; C Popescu; M Lazar; A Streinu-Cercel; V Arama; S S Arama
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

2.  DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism.

Authors:  Gaia Tabacco; Anda M Naciu; Carmelo Messina; Gianfranco Sanson; Luca Rinaudo; Roberto Cesareo; Stefania Falcone; Silvia Manfrini; Nicola Napoli; John P Bilezikian; Fabio M Ulivieri; Andrea Palermo
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.